SAS Output

18-JUN-2019 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 148 35 14 5 3 1 0 07/25/2016 215 87
        2 Cabozantinib   34 12 6 4 1 0      
        3 Crizotinib   28 6 0 0 0 0      
        4 Savolitinib   30 8 0 0 0 0      
            127 40 11 7 2 0      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 136 100 69 49 18 3 02/24/2017 177 77
        2 Tokyo-172 BCG   135 98 68 48 16 4      
        3 Prime + Tokyo-172 BCG   132 94 66 46 15 2      
            403 292 203 143 49 9      
 
  S1605-Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 Y 1 Atezolizumab 162 168 117 62 38 11 1 03/13/2017 208 93
            168 117 62 38 11 1      
 
  S1802-Pros, Stg IV, SST +/- Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 68 68 46 27 6 1 09/24/2018 245 101
            68 68 46 27 6 1      
 
    2 Y 1 Standard Systemic Therapy Only 1273 16 16 12 9 1 0 09/24/2018    
        2 SST + Surgery/RT   18 18 14 11 4 0      
            34 34 26 20 5 0      
 
  S1806-Blad, MIBC, ChemoRT +/- Atezolizumab 1 Y 0 Initial Registration 475 1 1 1 1 1 0 06/03/2019 130 60
            1 1 1 1 1 0      
 
    2 Y 1 Chemo + RT 475 1 1 1 1 1 0 06/03/2019    
            1 1 1 1 1 0      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   5 2 1 1 0 0 11/23/2016 61 37
            5 2 1 1 0 0      
 
  EA8143-RCC, HR, Surg +/- Nivolumab (PROSPER) 0 E Total Registrations   52 36 26 13 4 2 09/29/2017 275 135
            52 36 26 13 4 2      
 
    1 E Total Registrations   43 31 23 14 2 0 09/29/2017    
            43 31 23 14 2 0      
 
  EA8171-PROS, newly diagnosed, mpMRI for pre-op stagi 1 E Total Registrations   6 6 6 4 1 1 02/11/2019 81 32
            6 6 6 4 1 1      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   3 2 1 0 0 0 08/24/2017 228 110
            3 2 1 0 0 0      
 
    2 E Total Registrations   3 2 1 1 0 0 08/24/2017    
            3 2 1 1 0 0      
 
  NRGGU005-PROS, intmd risk, IGRT& SBRT vs IGRT& HF-IMRT 1 E Total Registrations   1 1 1 1 0 0 03/19/2019 53 26
            1 1 1 1 0 0      
 
  NRGGU006-PROS, post-RP PSA, SRT +/- ADT w/Apalutamide 1 E Total Registrations   2 2 2 2 0 0 03/22/2019 50 18
            2 2 2 2 0 0      
 
    2 E Total Registrations   2 2 2 2 0 0 03/22/2019    
            2 2 2 2 0 0      
 
No A031501-Bladder, MIBC/Loc Adv, Adjv Pembro vs Obs 0 E Total Registrations   38 35 20 7 0 0 05/03/2018 244 129
            38 35 20 7 0 0      
 
    1 E Total Registrations   37 36 25 10 2 0 05/03/2018    
            37 36 25 10 2 0      
 
  A031701-Bladder, ddGC for MIBC with DDR Tumor Alt 1 E Total Registrations   1 1 0 0 0 0 12/17/2018 97 43
            1 1 0 0 0 0      
 
    2 E Total Registrations   1 1 1 1 0 0 12/17/2018    
            1 1 1 1 0 0      
 
  EA8134-Penile, Local Adv, ILND +/- Chemo or ChemoRT 1 E Total Registrations   1 1 1 1 0 0 04/25/2019    
            1 1 1 1 0 0      
 
  EA8153-Pros, ADT + Abira +/- Cabazitaxel (CHAARTED2) 1 E Total Registrations   7 7 4 3 1 0 08/08/2018 232 94
            7 7 4 3 1 0      
 
  R0924-Pros, NADT+WPRT vs. NADT+P&SV RT 1 E Total Registrations   93 14 3 1 0 0 11/25/2013 260 114
            93 14 3 1 0 0